Avalon GloboCare Corp. (NASDAQ:CHGA) Stock Short Interest Falls 51.8%

Avalon GloboCare Corp. (NASDAQ:CHGA) saw a significant decrease in short interest in the month of September. As of September 15th, there was short interest totaling 33,188 shares, a decrease of 51.8% from the August 31st total of 68,808 shares. Approximately 3.9% of the company’s shares are short sold. Based on an average daily volume of 48,548 shares, the short-interest ratio is presently 0.7 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of Avalon GloboCare from a “sell (e)” rating to a “sell (e+)” rating in a research note on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Avalon GloboCare Price Performance

Shares of CHGA traded up $0.44 during mid-day trading on Wednesday, reaching $2.40. The company’s stock had a trading volume of 32,424,718 shares, compared to its average volume of 370,038. Avalon GloboCare has a 12-month low of $1.79 and a 12-month high of $49.20. The stock has a market cap of $2.69 million, a PE ratio of -0.17 and a beta of -0.05. The company’s 50 day moving average is $3.91 and its 200 day moving average is $6.51.

Avalon GloboCare (NASDAQ:CHGA) last posted its earnings results on Friday, August 14th. The company reported ($2.80) earnings per share for the quarter.

About Avalon GloboCare

Avalon GloboCare Corp. is a life sciences company focused on developing cell-based technologies and precision medicine applications. Its work has included regenerative medicine, cancer diagnostics, and therapeutic platforms designed to support the development of personalized healthcare treatments.

The company has also pursued technologies involving cellular processing, biomanufacturing, and related laboratory services. Avalon GloboCare’s activities have included collaborations and development programs intended to translate emerging cell and molecular science into clinical and commercial applications.

Avalon GloboCare was established in the mid-2010s and has been headquartered in Freehold, New Jersey.